Dementing disorders in the elderly exact a high cost in both human suffering and health care dollars and are the leading cause of the loss of employability and independent living in the older population. It has been known for many years that vitamin B12 (cobalamin) deficiency can cause dementia and other neurobehavioral symptoms which are indistinguishable from Alzheimer's disease. Prospective studies which employ specific methods of diagnosis investigating the role of cobalamin deficiency in dementia are needed. This proposal plans to determine the prevalence of cobalamin deficiency in the following groups of patients: 1) Unselected elderly patients; 2) patients presenting to memory and movement disorders clinics; 3) patients admitted to state mental hospitals; and 4) residents of nursing homes. Sensitive and specific gas chromatography/mass spectrometry assays for serum methylmalonic acid and homocysteine, two metabolites related to the two human cobalamin-dependent enzymes, will be used to confirm tissue deficiency in patients with low serum cobalamin levels. A group of elderly patients and a group of demented patients who are found to have low serum cobalamin levels will be recruited for two prospective studies which evaluate the pattern of hematologic, neurologic, radiographic, electroencephalographic and neuropsychological abnormalities present at baseline and after 8 weeks, 6 months and 1 year of parental cobalamin therapy. The patients in these studies with low serum cobalamin levels and elevated methylmalonic acid and/or homocysteine levels will be compared to the patients with low serum cobalamin levels and normal metabolites and to a group of control patients matched for age and sex without dementia or cobalamin deficiency. The prevalence of elevated cerebrospinal fluid methylmalonic acid levels will be evaluated in patients with low serum cobalamin levels also. This project is designed to determine the prevalence of biochemically significant cobalamin deficiency in elderly populations and patients with neurologic or psychiatric abnormalities. In addition, in two subsets of patients, the pattern of neurobehavioral abnormalities will be defined using sensitive, multifaceted methodology, and the nature and extent of response to cobalamin therapy will be determined.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG009417-02
Application #
3790414
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Kozora, E; Filley, C M; Julian, L J et al. (1999) Cognitive functioning in patients with chronic obstructive pulmonary disease and mild hypoxemia compared with patients with mild Alzheimer disease and normal controls. Neuropsychiatry Neuropsychol Behav Neurol 12:178-83
Filley, C M; Cullum, C M (1997) Education and cognitive function in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol 10:48-51
Miller, S W; Trimmer, P A; Parker Jr, W D et al. (1996) Creation and characterization of mitochondrial DNA-depleted cell lines with ""neuronal-like"" properties. J Neurochem 67:1897-907
Cullum, C M; Filley, C M; Kozora, E (1995) Episodic memory function in advanced aging and early Alzheimer's disease. J Int Neuropsychol Soc 1:100-3
Parker Jr, W D; Parks, J K (1995) Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization. Neurology 45:482-6
England, J D; Ferguson, M A; Hiatt, W R et al. (1995) Progression of neuropathy in peripheral arterial disease. Muscle Nerve 18:380-7
Parker Jr, W D; Mahr, N J; Filley, C M et al. (1994) Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology 44:1086-90
Parker Jr, W D; Parks, J; Filley, C M et al. (1994) Electron transport chain defects in Alzheimer's disease brain. Neurology 44:1090-6
England, J D; Gamboni, F; Ferguson, M A et al. (1994) Sodium channels accumulate at the tips of injured axons. Muscle Nerve 17:593-8